skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Labeled ALPHA4BETA2 ligands and methods therefor

Patent ·
OSTI ID:1082891

Contemplated compositions and methods are employed to bind in vitro and in vivo to an .alpha.4.beta.2 nicotinic acetylcholine receptor in a highly selective manner. Where such compounds are labeled, compositions and methods employing such compounds can be used for PET and SPECT analysis. Alternatively, and/or additionally contemplated compounds can be used as antagonists, partial agonists or agonists in the treatment of diseases or conditions associated with .alpha.4.beta..beta.2 dysfunction.

Research Organization:
DOESC (USDOE Office of Science (SC) (United States))
Sponsoring Organization:
USDOE
DOE Contract Number:
FG02-03ER63598
Assignee:
The Regents of the University of California (Oakland, CA)
Patent Number(s):
8,378,109
Application Number:
11/721,145
OSTI ID:
1082891
Country of Publication:
United States
Language:
English

References (9)

3-pyridyloxymethyl heterocyclic ether compounds useful in controlling neurotransmitter release patent September 1999
Nicotine derivatives that enhance cognitive function patent January 1994
3-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission patent May 1997
Heterocyclic ether compounds useful in controlling neurotransmitter release patent June 1999
Development of ligands for in vivo imaging of cerebral nicotinic receptors journal August 2000
Structure−Activity Studies on 2-Methyl-3-(2( S )-pyrrolidinylmethoxy)pyridine (ABT-089):  An Orally Bioavailable 3-Pyridyl Ether Nicotinic Acetylcholine Receptor Ligand with Cognition-Enhancing Properties journal January 1997
7A-heterocycle substituted hexahydro-1H-pyrrolizine compounds useful in controlling chemical synaptic transmission patent March 1998
Synthesis and structure-activity relationships of pyridine-modified analogs of 3-[2-((S)-pyrrolidinyl)methoxy]pyridine, A-84543, a potent nicotinic acetylcholine receptor agonist journal February 1998
Nicotinic receptor antagonists in the treatment of neuropharmacological disorders patent November 1997

Similar Records

The effect of smoking cessation pharmacotherapies on pancreatic beta cell function
Journal Article · Thu Nov 15 00:00:00 EST 2012 · Toxicology and Applied Pharmacology · OSTI ID:1082891

Mapping of the acetylcholine binding site of the nicotinic acetylcholine receptor: ( sup 3 H)nicotine as an agonist photoaffinity label
Journal Article · Tue Jul 16 00:00:00 EDT 1991 · Biochemistry; (United States) · OSTI ID:1082891

Long-term exposure to nicotine markedly reduces kynurenic acid in rat brain - In vitro and ex vivo evidence
Journal Article · Thu Oct 15 00:00:00 EDT 2009 · Toxicology and Applied Pharmacology · OSTI ID:1082891

Related Subjects